vs
Side-by-side financial comparison of MID PENN BANCORP INC (MPB) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $62.0M, roughly 1.2× MID PENN BANCORP INC). MID PENN BANCORP INC runs the higher net margin — 31.4% vs 7.4%, a 23.9% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs 25.5%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 21.1%).
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
MPB vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.0M | $76.2M |
| Net Profit | $19.4M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | 43.6% | 11.0% |
| Net Margin | 31.4% | 7.4% |
| Revenue YoY | 30.8% | 25.5% |
| Net Profit YoY | 47.0% | 30.7% |
| EPS (diluted) | $0.83 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.0M | $76.2M | ||
| Q3 25 | $61.8M | $71.9M | ||
| Q2 25 | $54.3M | $63.1M | ||
| Q1 25 | $47.7M | $59.1M | ||
| Q4 24 | $47.4M | $60.7M | ||
| Q3 24 | $45.3M | $58.0M | ||
| Q2 24 | $44.1M | $55.0M | ||
| Q1 24 | $42.3M | $50.6M |
| Q4 25 | $19.4M | $5.6M | ||
| Q3 25 | $18.3M | $3.5M | ||
| Q2 25 | $4.8M | $3.2M | ||
| Q1 25 | $13.7M | $2.6M | ||
| Q4 24 | $13.2M | $4.3M | ||
| Q3 24 | $12.3M | $3.9M | ||
| Q2 24 | $11.8M | $1.5M | ||
| Q1 24 | $12.1M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | 43.6% | 11.0% | ||
| Q3 25 | 39.3% | 7.8% | ||
| Q2 25 | 7.9% | 8.1% | ||
| Q1 25 | 35.2% | 6.5% | ||
| Q4 24 | 34.1% | 10.6% | ||
| Q3 24 | 32.8% | 9.7% | ||
| Q2 24 | 32.4% | 6.6% | ||
| Q1 24 | 34.8% | 4.4% |
| Q4 25 | 31.4% | 7.4% | ||
| Q3 25 | 29.6% | 4.9% | ||
| Q2 25 | 8.8% | 5.0% | ||
| Q1 25 | 28.8% | 4.4% | ||
| Q4 24 | 27.9% | 7.1% | ||
| Q3 24 | 27.1% | 6.7% | ||
| Q2 24 | 26.7% | 2.7% | ||
| Q1 24 | 28.7% | 3.2% |
| Q4 25 | $0.83 | $0.14 | ||
| Q3 25 | $0.79 | $0.09 | ||
| Q2 25 | $0.22 | $0.08 | ||
| Q1 25 | $0.71 | $0.06 | ||
| Q4 24 | $0.72 | $0.10 | ||
| Q3 24 | $0.74 | $0.10 | ||
| Q2 24 | $0.71 | $0.04 | ||
| Q1 24 | $0.73 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $814.1M | $141.5M |
| Total Assets | $6.1B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.5M | ||
| Q3 25 | — | $11.1M | ||
| Q2 25 | — | $20.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $17.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $8.8M | ||
| Q1 24 | — | $7.3M |
| Q4 25 | $814.1M | $141.5M | ||
| Q3 25 | $796.3M | $133.6M | ||
| Q2 25 | $775.7M | $139.7M | ||
| Q1 25 | $667.9M | $134.8M | ||
| Q4 24 | $655.0M | $131.4M | ||
| Q3 24 | $573.1M | $125.0M | ||
| Q2 24 | $559.7M | $119.4M | ||
| Q1 24 | $551.0M | $116.3M |
| Q4 25 | $6.1B | $199.2M | ||
| Q3 25 | $6.3B | $202.4M | ||
| Q2 25 | $6.4B | $184.6M | ||
| Q1 25 | $5.5B | $178.1M | ||
| Q4 24 | $5.5B | $177.1M | ||
| Q3 24 | $5.5B | $169.5M | ||
| Q2 24 | $5.4B | $163.9M | ||
| Q1 24 | $5.3B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $18.4M |
| Free Cash FlowOCF − Capex | $71.8M | $9.7M |
| FCF MarginFCF / Revenue | 115.8% | 12.7% |
| Capex IntensityCapex / Revenue | 13.3% | 11.5% |
| Cash ConversionOCF / Net Profit | 4.12× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $132.1M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | $18.4M | ||
| Q3 25 | $26.3M | $18.4M | ||
| Q2 25 | $29.0M | $12.3M | ||
| Q1 25 | $11.5M | $2.9M | ||
| Q4 24 | $51.4M | $15.0M | ||
| Q3 24 | $16.9M | $12.7M | ||
| Q2 24 | $18.0M | $10.2M | ||
| Q1 24 | $12.4M | $1.2M |
| Q4 25 | $71.8M | $9.7M | ||
| Q3 25 | $24.3M | $10.7M | ||
| Q2 25 | $27.2M | $4.1M | ||
| Q1 25 | $8.8M | $-12.6M | ||
| Q4 24 | $44.5M | $3.2M | ||
| Q3 24 | $16.8M | $1.7M | ||
| Q2 24 | $17.7M | $1.2M | ||
| Q1 24 | $12.1M | $-4.8M |
| Q4 25 | 115.8% | 12.7% | ||
| Q3 25 | 39.4% | 14.9% | ||
| Q2 25 | 50.1% | 6.5% | ||
| Q1 25 | 18.4% | -21.4% | ||
| Q4 24 | 93.8% | 5.2% | ||
| Q3 24 | 37.1% | 3.0% | ||
| Q2 24 | 40.2% | 2.3% | ||
| Q1 24 | 28.5% | -9.5% |
| Q4 25 | 13.3% | 11.5% | ||
| Q3 25 | 3.1% | 10.6% | ||
| Q2 25 | 3.2% | 12.9% | ||
| Q1 25 | 5.7% | 26.2% | ||
| Q4 24 | 14.6% | 19.5% | ||
| Q3 24 | 0.0% | 19.0% | ||
| Q2 24 | 0.7% | 16.3% | ||
| Q1 24 | 0.8% | 11.9% |
| Q4 25 | 4.12× | 3.27× | ||
| Q3 25 | 1.44× | 5.23× | ||
| Q2 25 | 6.08× | 3.88× | ||
| Q1 25 | 0.84× | 1.09× | ||
| Q4 24 | 3.88× | 3.47× | ||
| Q3 24 | 1.37× | 3.29× | ||
| Q2 24 | 1.53× | 6.94× | ||
| Q1 24 | 1.02× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
